Norges Bank’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $16M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $23.4M | Sell |
|
|||||
|
2024
Q3 | $23.5M | Buy |
|
|||||
|
2024
Q2 | $14.6M | Sell |
|
|||||
|
2024
Q1 | $31.6M | Sell |
|
|||||
|
2023
Q4 | $34.8M | Buy |
|
|||||
|
2023
Q3 | $26.2M | Buy |
|
|||||
|
2023
Q2 | $21.4M | Sell |
|
|||||
|
2023
Q1 | $28.2M | Sell |
|
|||||
|
2022
Q4 | $33.7M | Hold |
|
|||||
|
2022
Q3 | $46.5M | Buy |
|
|||||
|
2022
Q2 | $34.6M | Buy |
|
|||||
|
2022
Q1 | $10M | Buy |
|
|||||
|
2021
Q4 | $23.9M | Buy |
|
|||||
|
2021
Q3 | $11.5M | Hold |
|
|||||
|
2021
Q2 | $18.3M | Buy |
|